Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2010 - 2026)

Alnylam Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.85 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 52.88% year-over-year to 0.85 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.85 (up 52.88% YoY) and the FY2025 annual result came in at 0.81, up 44.8% from the prior year.
• Asset Utilization Ratio was 0.85 for Q1 2026 at Alnylam Pharmaceuticals, up from 0.76 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.85 in Q1 2026 and bottomed at 0.25 in Q1 2022.
• A 5-year average of 0.49 and a median of 0.51 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 70.06% — and 2025, when it declined 6.3%.
• Alnylam Pharmaceuticals' Asset Utilization Ratio stood at 0.29 in 2022, then surged by 62.74% to 0.48 in 2023, then advanced by 11.67% to 0.53 in 2024, then surged by 42.09% to 0.76 in 2025, then climbed by 12.25% to 0.85 in 2026.
• Business Quant data shows ALNY's Asset Utilization Ratio at 0.85 in Q1 2026, 0.76 in Q4 2025, and 0.68 in Q3 2025.